Cytodyn Inc (CYDY)

[CTMedic]

Blane and Latane,

I would like nothing more at this juncture than an outstanding vaccine. There is not a doubt in my mind that there will be insufficient leronlimab to treat everyone who would need it for Covid alone, much less HIV, cancers, Alzheimer’s and the dozens of diseases Ohm has recognized as likely leronlimab indications.

The global mAb production capacity is reportedly 16 million liters annually, which yields 64 million grams of concentrate mAb or just shy of 200 million 350 mg doses. Patients need multiple doses and the global mAb production will not be diverted IMO to leronlimab.

Let’s hope Covid and other illnesses can be prevented with vaccines and save leronlimab for those who would otherwise suffer greatly or die.